N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor

Details for Australian Patent Application No. 2002303094 (hide)

Owner Eli Lilly and Company

Inventors Miller, Shawn Christopher; Schaus, John Mehnert; Fisher, Matthew Joseph; McCowan, Jefferson Ray; Gillig, James Ronald; Chen, Zhaogen; Cohen, Michael Philip; Giethlen, Bruno

Agent Spruson & Ferguson

Pub. Number AU-B-2002303094

PCT Number PCT/US02/05115

PCT Pub. Number WO2002/078693

Priority 60/329,449 15.10.01 US; 60/279,928 29.03.01 US

Filing date 15 March 2002

Wipo publication date 15 October 2002

Acceptance publication date 23 November 2006

International Classifications

A61K 31/4045 (2006.01)

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07C 217/54 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 317/14 (2006.01) Sulfones

C07C 323/01 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 209/14 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/16 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 233/24 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 277/34 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/91 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 60/329,449 15.10.01 US; 60/279,928 29.03.01 US

3 April 2003 Application Open to Public Inspection

  Published as AU-B-2002303094

23 November 2006 Application Accepted

  Published as AU-B-2002303094

22 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303095-IMPROVED PROSTANOID THERAPIES FOR THE TREATMENT OF GLAUCOMA

2002303093-METHODS AND COMPOSITIONS FOR THERAPEUTIC INTERVENTION IN INFECTIOUS DISEASE